Erosive pustular dermatosis of the scalp: a multicentre study.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 03 10 2019
accepted: 17 12 2019
pubmed: 19 1 2020
medline: 15 5 2021
entrez: 19 1 2020
Statut: ppublish

Résumé

Erosive pustular dermatosis of the scalp (EPDS) is characterized by crusted erosions or superficial ulcerations that lead to scarring alopecia. We performed a multicentre retrospective clinical study including 56 patients (29 females and 27 males, mean age 62.7) with a confirmed EPDS in order to describe epidemiology, clinical findings and therapeutic choices of this disease. Mechanical/chemical trauma was reported in 28.6%, a previous infection in 10.7%, a previous cryotherapy in 5.4% androgenetic alopecia in 48.2% and severe actinic damage in 25%. Trichoscopy showed absence of follicular ostia, tufted and broken hair, crusts, serous exudate, dilated vessels, pustules and hyperkeratosis. Histopathology revealed three different features, depending on the disease duration. The most prescribed therapy was topical steroids (62.5%), followed by the combination of topical steroids and topical tacrolimus (8.9%), systemic steroids (7.1%) and topical tacrolimus (5.4%). A reduction of inflammatory signs was observed in 28 patients (50%) treated with topical steroids and in all three patients treated with topical tacrolimus. The relatively high number of patients collected allowed us to identify a better diagnostic approach, using trichoscopy and a more effective therapeutic strategy, with high-potency steroids or tacrolimus, which should be considered as first-line treatment.

Sections du résumé

BACKGROUND BACKGROUND
Erosive pustular dermatosis of the scalp (EPDS) is characterized by crusted erosions or superficial ulcerations that lead to scarring alopecia.
OBJECTIVES AND METHODS OBJECTIVE
We performed a multicentre retrospective clinical study including 56 patients (29 females and 27 males, mean age 62.7) with a confirmed EPDS in order to describe epidemiology, clinical findings and therapeutic choices of this disease.
RESULTS RESULTS
Mechanical/chemical trauma was reported in 28.6%, a previous infection in 10.7%, a previous cryotherapy in 5.4% androgenetic alopecia in 48.2% and severe actinic damage in 25%. Trichoscopy showed absence of follicular ostia, tufted and broken hair, crusts, serous exudate, dilated vessels, pustules and hyperkeratosis. Histopathology revealed three different features, depending on the disease duration. The most prescribed therapy was topical steroids (62.5%), followed by the combination of topical steroids and topical tacrolimus (8.9%), systemic steroids (7.1%) and topical tacrolimus (5.4%). A reduction of inflammatory signs was observed in 28 patients (50%) treated with topical steroids and in all three patients treated with topical tacrolimus.
CONCLUSION CONCLUSIONS
The relatively high number of patients collected allowed us to identify a better diagnostic approach, using trichoscopy and a more effective therapeutic strategy, with high-potency steroids or tacrolimus, which should be considered as first-line treatment.

Identifiants

pubmed: 31954062
doi: 10.1111/jdv.16211
doi:

Substances chimiques

Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1348-1354

Informations de copyright

© 2020 European Academy of Dermatology and Venereology.

Références

Starace M, Loi C, Bruni F et al. Erosive pustular dermatosis of the scalp: clinical, trichoscopic, and histopathologic features of 20 cases. J Am Acad Dermatol 2017; 76: 1109-1114.e2.
Pye RJ, Peachey RD, Burton JL. Erosive pustular dermatosis of the scalp. Br J Dermatol 1979; 100: 559-566.
Fertig R, Maddy A, Cadore de Farias D, Simão Corrêa Filho S, Rigatti M, Tosti A. Erosive pustular dermatosis of the scalp after aplasia cutis congenita in a 9-year-old patient: a 5-year follow-up. Pediatr Dermatol 2017; 34: 695-696.
Poenitz N, Tadler D, Klemke CD, Glorer E, Goerdt S. Ulceration of the scalp: a unique manifestation of pyoderma gangrenosum. J Dtsch Dermatol Ges 2005; 3: 113-116.
Van Exel CE, English JC 3rd. Erosive pustular dermatosis of the scalp and nonscalp. J Am Acad Dermatol 2007; 57(2 Suppl): S11-S14.
Thuraisingam T, Mirmirani P. Erosive pustular dermatosis: a manifestation of immunosenescence a report of 8 cases. Skin Appendage Disord 2018; 4: 180-186.
Caputo R, Veraldi S. Erosive pustular dermatosis of the scalp. J Am Acad Dermatol 1993; 28: 96-98. Review.
Kim KR, Lee JY, Kim MK, Yoon TY. Erosive pustular dermatosis of the scalp following herpes zoster: successful treatment with topical tacrolimus. Ann Dermatol 2010; 22: 232-234.
Trüeb RM, Krasovec M. Erosive pustular dermatosis of the scalp following radiation therapy for solar keratoses. Br J Dermatol 1999; 141: 763-765.
Watanabe S, Takizawa K, Hashimoto N, Ishibashi Y. Pustular dermatosis of the scalp associated with autoimmune diseases. J Dermatol 1989; 16: 383-387.
Yamamoto T, Furuse Y. Erosive pustular dermatosis of the scalp in association with rheumatoid arthritis. Int J Dermatol 1995; 34: 148.
Mastroianni A, Cota C, Ardigò M, Minutilli E, Berardesca E. Erosive pustular dermatosis of the scalp: a case report and review of the literature. Dermatology 2005; 211: 273-276. Review.
Semkova K, Tchernev G, Wollina U. Erosive pustular dermatosis (chronic atrophic dermatosis of the scalp and extremities). Clin Cosmet Investig Dermatol 2013; 6: 177-182.
Uva L, Aphale AN, Kehdy J, Benedetto AV. Erosive pustular dermatosis successfully treated with a novel silicone gel. Int J Dermatol 2016; 55: 89-91.
Wilk M, Zelger BG, Hauser U, Höpfl R, Zelger B. Erosive pustular dermatosis of the scalp: reappraisal of an underrecognized entity. J Dtsch Dermatol Ges 2018; 16: 15-19.
Tomasini C, Michelerio A. Erosive pustular dermatosis of the scalp: a neutrophilic folliculitis within the spectrum of neutrophilic dermatoses: a clinicopathologic study of 30 cases. J Am Acad Dermatol 2018; 81: 527-533.
Guarneri C, Cannavò SP. Erosive pustular dermatosis of the scalp from topical minoxidil 5% solution. Int J Dermatol 2013; 52: 507-509.
Corradin MT, Forcione M, Giulioni E, Fiorentino R, Ferrazzi A, Alaibac M. Erosive pustular dermatosis of the scalp induced by imiquimod. Case Rep Dermatol Med 2012; 2012: 828749.
Drouin CA, Cloutier RA. Recurrence of erosive pustular scalp dermatosis after a skin graft. Ann Dermatol Venereol 1999; 126: 335-338.
Vaccaro M, Barbuzza O, Borgia F, Cannavò SP. Erosive pustular dermatosis of the scalp following topical latanoprost for androgenetic alopecia. Dermatol Ther 2015; 28: 65-67.
Patton D, Lynch PJ, Fung MA, Fazel N. Chronic atrophic erosive dermatosis of the scalp and extremities: a recharacterization of erosive pustular dermatosis. J Am Acad Dermatol 2007; 57: 421-427.
Broussard KC, Berger TG, Rosenblum M, Murase JE. Erosive pustular dermatosis of the scalp: a review with a focus on dapsone therapy. J Am Acad Dermatol 2012; 66: 680-686.
Guarneri C, Vaccaro M. Erosive pustular dermatosis of the scalp following topical methylaminolaevulinate photodynamic therapy. J Am Acad Dermatol 2009; 60: 521-522.
Meyer T, López-Navarro N, Herrera-Acosta E, Jose A, Herrera E. Erosive pustular dermatosis of the scalp: a successful treatment with photodynamic therapy. Photodermatol Photoimmunol Photomed 2010; 26: 44-45.
Grubbs HE, Robb CW. Successful use of a fractional 2940-nm laser in treating chronic, severe erosive pustular dermatosis of the scalp. JAAD Case Rep 2019; 5: 188-190.

Auteurs

M Starace (M)

Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.

M Iorizzo (M)

Private Dermatology Practice - Lugano & Bellinzona, Bellinzona, Switzerland.

R M Trüeb (RM)

Center for Dermatology and Hair Disease Professor Trüeb, Zürich-Wallisellen, Switzerland.

V Piccolo (V)

Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

G Argenziano (G)

Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

F M Camacho (FM)

Department of Dermatology, University of Seville, Seville, Spain.
Doctor Honoris Causa from University of Cadiz, Cadiz, Spain.

Y Gallyamova (Y)

State Budget Educational Institution of Additional Professional Education "Russian Medical Academy of Postgraduate Education Studies" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.

L Rudnicka (L)

Department of Dermatology, Medical University of Warsaw, Warsaw, Poland.

I Umbert (I)

Instituto de Dermatologia Ignacio Umbert (Private Research Institute), Barcelona, Spain.

A Lyakhovitsky (A)

Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.

S Vañó-Galván (S)

Department of Dermatology - Trichology Unit, Ramon y Cajal Hospital, Madrid, Spain.

A Goren (A)

Department of Dermatology, University of Rome G. Marconi, Rome, Italy.

A Alessandrini (A)

Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.

F Bruni (F)

Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.

B M Piraccini (BM)

Department of Experimental, Diagnostic and Specialty Medicine - Division of Dermatology, University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH